6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE
Synonym(s):4-N-[2-(4-Phenoxyphenyl)ethyl]quinazoline-4,6-diamine;6-Amino-4-(4-phenoxyphenylethylamino)quinazoline;N4-[2-(4-Phenoxyphenyl)ethyl]-4,6-quinazolinediamine;NF-κB Activation Inhibitor - CAS 545380-34-5 - Calbiochem;QNZ
- CAS NO.:545380-34-5
- Empirical Formula: C22H20N4O
- Molecular Weight: 356.42
- MDL number: MFCD06411436
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-09 19:38:33
What is 6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE?
Description
QNZ (545380-34-5) was originally described as a potent inhibitor of NF-κB activation (IC50?= 11 nM) and TNF-α?production (IC50?= 7 nM).1,2?It indirectly inhibits the NF-κB pathway via inhibition of store-operated calcium entry (SOC) and displayed neuroprotective effects in transgenic fly and mouse models of Huntington’s disease.3,4?Its target has been postulated to be heteromeric calcium channels containing TRPC1 as one of the subunits.4?QNZ reduced synaptic neuronal SOC and rescued dendritic spine loss in YAC128 striatal medium spiny neurons.5?QNZ has also been identified as a potent (IC50?= 25 nM complex 1 from?Y.lipolytica; IC50?= 14 nM complex 1 from?Bos Taurus?heart mitochondria) and selective inhibitor of mitochondrial complex I.6?QNZ?decreased PSEN1ΔE9-mediated nSOCE upregulation and rescued mushroom spines in PSEN1ΔE9-expressing neurons, which are linked to familial Alzheimer’s disease.7
Chemical properties
White Solid
The Uses of 6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE
QNZ is a novel inhibitor of NFkB which displays potent inhibitory effects on both NFKB transcriptional activation (IC50=11nM) and TNF-a production (IC50=7nM). It dose-dependently inhibited carragenin-induced edema formation in the rat paw model (1m
The Uses of 6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE
QNZ is an inhibitor of NF-κB activation with IC50 of 11 nM.
What are the applications of Application
QNZ is an inhibitor of the transcription factor NFκB
References
1) Tobe?et al. (2003),?Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation; Bioorg. Med. Chem. Lett,?11?383 2) Tobe?et al.?(2003),?A novel structural class of potent inhibitors of NF-kB activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives; Bioorg. Med. Chem. Lett,?11?3869 3) Choi?et al.?(2006),?Nuclear factor-kappaB activated by capacitive Ca2+ entry enhances muscarinic receptor-mediated soluble amyloid precursor protein (sAPPalpha) release in SH-SY5Y cells; J. Biol. Chem.,?281?12722 4) Wu?et al.?(2011),?Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntington’s Disease Treatment; Chem. Biol.,?18?777 5) Wu?et al. (2016),?Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington’s Disease Mouse Model; J. Neurosci.,?36?125 6) Krishnathas?et al. (2017),?Identification of 4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine as a novel, highly potent and specific inhibitor of mitochondrial complex I; Medchemcomm.?8?657 7) Chernyuk?et al. (2019),?Antagonist of neuronal store-operated calcium entry exerts beneficial effects in neurons expressing PSEN1?E9 mutant linked to familial Alzheimer disease;?Neuroscience,?410?118
Properties of 6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE
Melting point: | 169-175°C |
storage temp. | Keep in dark place,Inert atmosphere,2-8°C |
solubility | DMSO: soluble15mg/mL, clear |
form | powder |
color | white to beige |
Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month. |
Safety information for 6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE
Computed Descriptors for 6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE
New Products
ALUMINIUM IODIDE 100 GM BUFFER CAPSULE PH 7.0 - 10 CAP BUFFER SOLUTION PH 9.5 (BORATE) EZEE BLUE GEL STAINER BORAX CARMINE (GRENACHERS ALCOHOLIC) POTASSIUM IODATE - IODIDE SOLN 0.1 N Dabigatran Acyl-O3-D-Glucuronide Trifluoroacetic Acid Salt Isofolic Acid Dabigatran 2-O-acylglucuronide metabolite Dabigatran Acyl-?-D- glucuronide Trifluroacetic Acid Erythromycin EP Impurity A Desloratidine Related Compound ARelated products of tetrahydrofuran
You may like
-
NF-κB Activation Inhibitor CASView Details
-
NF-κB Activation Inhibitor CAS 545380-34-5View Details
545380-34-5 -
Dechloro DesloratadineView Details
-
Dehydro DesloratadineView Details
-
Edoxaban Impurity 57View Details
2089454-69-1 -
Empagliflozin Bromo ImpurityView Details
-
Glycopyrronium Bromide EP Impurity IView Details
1404617-94-2 -
Ipratropium EP Impurity BView Details
58073-59-9